LOGC
BlackRock’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-170,945
| Closed | -$47K | – | 5835 |
|
|
2022
Q3 | $47K | Sell |
170,945
-3,509
| -2% | -$965 | ﹤0.01% | 5287 |
|
|
2022
Q2 | $61K | Sell |
174,454
-41,662
| -19% | -$14.6K | ﹤0.01% | 5284 |
|
|
2022
Q1 | $146K | Sell |
216,116
-2,493
| -1% | -$1.68K | ﹤0.01% | 5106 |
|
|
2021
Q4 | $506K | Buy |
218,609
+2,873
| +1% | +$6.65K | ﹤0.01% | 4796 |
|
|
2021
Q3 | $988K | Sell |
215,736
-5,412
| -2% | -$24.8K | ﹤0.01% | 4496 |
|
|
2021
Q2 | $982K | Sell |
221,148
-762,863
| -78% | -$3.39M | ﹤0.01% | 4454 |
|
|
2021
Q1 | $7.16M | Buy |
984,011
+80,284
| +9% | +$585K | ﹤0.01% | 3703 |
|
|
2020
Q4 | $6.9M | Buy |
903,727
+183,768
| +26% | +$1.4M | ﹤0.01% | 3487 |
|
|
2020
Q3 | $6.54M | Buy |
719,959
+21,592
| +3% | +$196K | ﹤0.01% | 3368 |
|
|
2020
Q2 | $5.91M | Buy |
698,367
+200,218
| +40% | +$1.69M | ﹤0.01% | 3389 |
|
|
2020
Q1 | $2.46M | Sell |
498,149
-7,131
| -1% | -$35.2K | ﹤0.01% | 3530 |
|
|
2019
Q4 | $3.64M | Buy |
505,280
+38,159
| +8% | +$275K | ﹤0.01% | 3537 |
|
|
2019
Q3 | $5.05M | Buy |
467,121
+15,398
| +3% | +$166K | ﹤0.01% | 3441 |
|
|
2019
Q2 | $5.87M | Buy |
451,723
+85,079
| +23% | +$1.11M | ﹤0.01% | 3445 |
|
|
2019
Q1 | $3.62M | Sell |
366,644
-10,910
| -3% | -$108K | ﹤0.01% | 3486 |
|
|
2018
Q4 | $3.93M | Buy |
+377,554
| New | +$3.93M | ﹤0.01% | 3451 |
|